SKAN Group AGFRA:7VG +2.61%62 PEG Ratio is 7.62 as of Jul. 11, 2026, which is 11% above its 10-year median of 6.86. GuruFocus rates FRA:7VG with a GF Score™ of 62/100 and a GF Value™ of €90.87 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 208 Medical Devices & Instruments companies, SKAN Group AG ranks worse than 89.42% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for SKAN Group AG's PEG Ratio or its related term are showing as below:
FRA:7VG'
s PEG Ratio Range Over the Past 10 Years
Min: 5.89 Med: 6.86 Max: 8.53
Current: 8.17
During the past 6 years, SKAN Group AG's highest PEG Ratio was 8.53. The lowest was 5.89. And the median was 6.86.
FRA:7VG's PEG Ratio is ranked worse than 89.42% of 208
companies
in the Medical Devices & Instruments industry
Industry Median: 1.895
vs FRA:7VG: 8.17
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
SKAN Group AG (FRA:7VG) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
SKAN Group AG PEG Ratio Related Terms
SKAN Group AG PEG Ratio Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, SKAN Group AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's PEG Ratio distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
SKAN Group AG (FRA:7VG) has a PEG Ratio of 7.62 as of Jul. 11, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on SKAN Group AG and its competitors. This is 11% above median its historical median of 6.86. Over the past decade, SKAN Group AG's PEG Ratio has ranged from 5.89 to 8.53. According to the industry distribution chart, SKAN Group AG ranks #186 out of 208 companies in the Medical Devices & Instruments industry, placing it in the top 89.4%.
Is SKAN Group AG's PEG Ratio too high?
SKAN Group AG's current PEG Ratio of 7.62 is 11% above median its 10-year median of 6.86. Over the past 10 years, this metric has ranged from a low of 5.89 to a high of 8.53. The Medical Devices & Instruments industry median PEG Ratio is 1.90. SKAN Group AG's value of 7.62 is 302.1% above this industry median. Based on the distribution chart, SKAN Group AG ranks #186 out of 208 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SKAN Group AG has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #186 out of 208 companies for PEG Ratio. This places SKAN Group AG in the lower half of its industry. The industry median PEG Ratio is 1.90. SKAN Group AG's value of 7.62 is 302.1% above this benchmark. Historically, SKAN Group AG's own PEG Ratio has ranged from 5.89 to 8.53 over the past decade. While the company's 10-year median is 6.86 vs. the industry median of 1.90, SKAN Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.90, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SKAN Group AG's current PEG Ratio of 7.62 is 302.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current PEG Ratio is 7.62, which is 11% above median its own 10-year median of 6.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €90.87, compared to a current price of €59.00 — trading 35.1% below its estimated fair value. The current PEG Ratio is 7.62, which is 11% above median its 10-year median of 6.86 and 302.1% above the Medical Devices & Instruments industry median of 1.90. SKAN Group AG's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current PEG Ratio is 7.62 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (FRA:7VG) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of €59.00 is trading 35.1% below its estimated GF Value™ of €90.87.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for FRA:7VG:
PEG Ratio: 7.62 (11% above median its 10-year median of 6.86)
GF Value™: €90.87 vs. price of €59.00 (35.1% below fair value)
Industry Position: 302.1% above the Medical Devices & Instruments median (#186 of 208)
No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
62GF Score
Get the complete analysis for FRA:7VG
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7VG has been successfully added to your 
